Barth syndrome
(Redirected from 3 alpha methylglutaconic aciduria, type 3)
A rare genetic disorder affecting multiple systems
Barth Syndrome | |
---|---|
![]() | |
Synonyms | 3-Methylglutaconic aciduria type II, X-linked cardioskeletal myopathy and neutropenia, BTHS, Cardioskeletal myopathy with neutropenia and abnormal mitochondria, Cardioskeletal myopathy-neutropenia syndrome |
Pronounce | |
Field | Medical genetics, Pediatrics, Cardiology |
Symptoms | Dilated cardiomyopathy, Neutropenia, Short stature, Muscle weakness |
Complications | N/A |
Onset | Infancy |
Duration | Lifelong |
Types | |
Causes | TAZ gene mutation (X-linked recessive) |
Risks | |
Diagnosis | Genetic testing, Echocardiogram, Blood test |
Differential diagnosis | Other mitochondrial diseases, Primary immunodeficiency |
Prevention | None |
Treatment | Symptomatic management |
Medication | Antibiotics, Heart failure medications |
Prognosis | Variable; reduced life expectancy possible |
Frequency | 1–9 per 1,000,000 |
Deaths |
Barth syndrome is a rare genetic disorder that primarily affects males. It is characterized by a combination of symptoms including cardiomyopathy, neutropenia, skeletal muscle weakness, growth delay, and abnormal mitochondrial function. The condition is caused by mutations in the TAZ gene, which is located on the X chromosome and affects the metabolism of cardiolipin, a key phospholipid in mitochondrial membranes.
Genetics[edit | edit source]
Barth syndrome is inherited in an X-linked recessive pattern. Since males have only one X chromosome, a single mutation in the TAZ gene is sufficient to cause the disorder. Females can be carriers and may show mild symptoms due to lyonization (random X-inactivation).
The TAZ gene encodes the enzyme tafazzin, which plays a crucial role in the remodeling of cardiolipin. Cardiolipin is an essential component of inner mitochondrial membranes, and its proper structure is vital for mitochondrial energy production. Mutations in TAZ lead to dysfunctional cardiolipin and mitochondrial impairment.
Clinical Features[edit | edit source]
Cardiomyopathy[edit | edit source]
The most serious manifestation is dilated cardiomyopathy, in which the heart becomes enlarged and weak, often leading to heart failure. Some patients may also have endocardial fibroelastosis, a thickening of the inner heart wall.
Neutropenia[edit | edit source]
Neutropenia, or a low count of neutrophils, increases the risk of bacterial infections. The degree of neutropenia can fluctuate and may be severe in some individuals.
Muscle Weakness and Fatigue[edit | edit source]
Affected individuals often experience muscle hypotonia and exercise intolerance due to mitochondrial energy deficiency.
Growth Delay[edit | edit source]
Short stature and delayed puberty are common features. These may result from nutritional deficiencies, chronic illness, or metabolic dysfunction.
Diagnosis[edit | edit source]
Diagnosis involves a combination of clinical evaluation, family history, and diagnostic testing:
- Genetic testing to identify mutations in the TAZ gene
- Blood tests showing neutropenia or elevated 3-methylglutaconic acid
- Echocardiography to detect cardiomyopathy
- Muscle biopsy or mitochondrial function tests in selected cases
Management[edit | edit source]
There is no cure for Barth syndrome. Treatment is supportive and includes:
- Medications for heart failure, including beta-blockers, ACE inhibitors, and diuretics
- Antibiotic prophylaxis or treatment for infections
- Granulocyte colony-stimulating factor (G-CSF) for severe neutropenia
- Nutritional support and growth monitoring
- Physical therapy to improve strength and mobility
Multidisciplinary care from cardiologists, geneticists, immunologists, and nutritionists is essential.
Prognosis[edit | edit source]
The prognosis varies depending on the severity of cardiac and hematological complications. With early detection and appropriate management, many individuals survive into adulthood, although some may experience reduced life expectancy due to heart failure or infections.
See also[edit | edit source]
- Genetic disorders
- Cardiomyopathy
- Mitochondrial diseases
- Neutropenia
- Tafazzin
- X-linked recessive inheritance
External links[edit | edit source]
NIH genetic and rare disease info[edit source]
Barth syndrome is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD